Sponsored
25 September 2025
Zenrelia is a NEW JAK inhibitor containing ilunocitinib for dogs with allergic and atopic dermatitis. Over half a million dogs have been treated with Zenrelia in the past 12 months in Brazil, USA, Japan, and Canada2 – a testament to Zenrelia’s efficacy and safety.
Elanco
Did you know that 79% of owners expect their dog to be back to normal when vets treat their itch? 3 The reality is a little different, with 53% of dogs treated with Apoquel getting back to normal. 1†††
Karen is a spayed Toy Poodle. She presented with severe pruritus and clear ocular discharge. She had significant saliva staining on her paws, forelimbs and mouth. The owner noted that Karen was not only extremely itchy, but that she had been more irritable than usual, affecting her quality of life.
Her owner’s goal was to provide treatment that would control Karen’s pruritus and improve her quality of life.
The treatment plan
“Karen is no longer itching and is in a much better mood!”
Chessie Green, Karen’s veterinary surgeon.
Maze is a neutered Staffordshire Bull Terrier. His owner reported that he had suffered from year-round pruritus and that previous therapies including Apoquel, steroids and antihistamines had sadly been unsuccessful at controlling his symptoms. On presentation he had severe pruritus, epidermal collarettes, alopecia and erythema.
His owner’s goal was to give a treatment that would manage Maze’s symptoms by providing year-round relief.
The treatment plan
“Incredible resolution of pruritus based on the PVAS score alone.”
Brooke West, Maze’s veterinary surgeon.
Zenrelia has a safety profile comparable to Apoquel.1 It can be given alongside commonly used medications, including vaccines, antibiotics, parasiticides, ear cleaners, sedatives, anaesthetics and NSAIDs (non-steroidal anti-inflammatory drugs).1, 4 †α It is well-tolerated when given long-term for maintenance therapy. 5‡
Zenrelia™ film coated tablets contain ilunocitinib. Legal category POM-V in UK, POM in IE. For further information call Elanco Animal Health on +44(0)1256 353131 or write to: Elanco UK AH Limited, Form 2, Bartley Way, Bartley Wood Business Park, Hook, RG27 9XA, United Kingdom. For further information, consult the product SPC. Zenrelia, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. Apoquel® is a trademark of Zoetis UK Limited & Zoetis Belgium (IE).
©2025 Elanco or its affiliates PM-IE-25-0179 Date of preparation 09/25
Advice should be sought from the medicine prescriber prior to use. Prescription decisions are for the person issuing the prescription alone.
Use medicines responsibly www.noah.co.uk/responsible www.apha.ie
